z-logo
Premium
Thermodynamic analysis of ligands at cholecystokinin CCK 2 receptors in rat cerebral cortex
Author(s) -
Harper E A,
Roberts S P,
Kalindjian S B
Publication year - 2007
Publication title -
british journal of pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.432
H-Index - 211
eISSN - 1476-5381
pISSN - 0007-1188
DOI - 10.1038/sj.bjp.0707355
Subject(s) - receptor , cholecystokinin , chemistry , radioligand , population , agonist , medicine , tris , endocrinology , biophysics , biochemistry , biology , environmental health
Background and purpose: Several studies using radioligand binding assays, have shown that measurement of thermodynamic parameters can allow discrimination of agonists and antagonists ( Weiland et al ., 1979 ; Borea et al ., 1996a ). Here we investigate whether agonists and antagonists can be thermodynamically discriminated at CCK 2 receptors in rat cerebral cortex. Experimental approach: The pK L of [ 3 H]‐JB93182 in rat cerebral cortex membranes was determined at 4, 12, 21 and 37°C in 50 m M Tris‐HCl buffer (buffer B pH 6.96; containing 0.089 m M bacitracin). pK I values of ligands of diverse chemical structure and with differing intrinsic activity ( α ), as defined by the lumen‐perfused rat and mouse stomach bioassays, were determined in buffer B at 4, 12, 21 and 37°C. Key results: [ 3 H]‐JB93182 labelled a homogeneous population of receptors in rat cerebral cortex at 4, 12, 21 and 37°C and the pK L and B max were not altered by incubation temperature. [ 3 H]‐JB93182 binding reached equilibrium after 10, 50, 90 and 220 min at 37, 21, 12 and 4°C, respectively. pK I values for R ‐L‐365,260, R ‐L‐740,093, YM220, PD134,308 and JB95008 were higher at 4°C than at 37°C. There was no effect of temperature on pK I values for pentagastrin, CCK‐8S, S ‐L‐365,260, YM022, PD140,376 and JB93242. Conclusions and implications: CCK 2 receptor agonists and antagonists at rat CCK 2 receptors cannot be discriminated by thermodynamic analysis using [ 3 H]‐JB93182 as the radioligand. British Journal of Pharmacology (2007) 151 , 1352–1367; doi: 10.1038/sj.bjp.0707355

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom